Non-ptotic ocular myasthenia gravis: A common presentation of an uncommon disease

Conti-Fine, 1997 Porter, 2005, Ocular myasthenia gravis, Curr Treat Options Neurol, 7, 79, 10.1007/s11940-005-0009-z Engel, 1984, Myasthenia gravis and myasthnic syndromes, Ann Neurol, 16, 519, 10.1002/ana.410160502 Sampson, 1981, Myasthenia gravis and myasthenic syndromes, 585 Kurland, 1961, Current status in epidemiology and genetics of myasthenia gravis, 307 Somnier, 1991, Epidemiology of myasthenia gravis in Denmark, Arch Neurol, 48, 733, 10.1001/archneur.1991.00530190081019 Kalb, 2002, Epidemiology of myasthenia gravis a population-based study in Stockholm, Sweden, Neuroepidemiology, 21, 221, 10.1159/000065639 Kupersmith, 2003, Development of generalized disease at 2 years in patients with ocular myasthenia gravis, Arch Neurol, 60, 243, 10.1001/archneur.60.2.243 Evoli, 2002, Thymoma in patients with MG, Neurology, 59, 1844, 10.1212/01.WNL.0000032502.89361.0C Cooper, 1988, The pathognomic pattern of accommodative fatigue in myasthenia gravis, Binoc Vis Eye Muscle Surg Q, 3, 141 Lertchavanakul, 2001, Ice test for ocular myasthenia gravis, J Med Assoc Thai, 84, S131 Golnik, 1999, The ice test in the diagnosis of myasthenia gravis, Ophthalmology, 106, 1282, 10.1016/S0161-6420(99)00709-5 Kubis, 2000, The ice test versus the rest test in myasthenia gravis, Ophthalmology, 107, 1995, 10.1016/S0161-6420(00)00458-9 Ellis, 2000, Extraocular muscle responses to orbital cooling (Ice Test) for ocular myasthenia gravis diagnosis, Am Assoc Pediatr Ophth Surg, 4, 271 Soliven, 1988, Seronegative myasthenia gravis, Neurology, 38, 514, 10.1212/WNL.38.4.514 Limburg, 1983, Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 1. Relation to clinical parameters in 250 patients, J Neurol Sci, 58, 357, 10.1016/0022-510X(83)90095-3 Skorin, 1991, Myasthenia gravis, 1 Howard, 1994, The electrodiagnosis of myasthenia gravis and the Lambert-Eaton myasthenic syndrome, Neurol Clin North Am, 12, 305, 10.1016/S0733-8619(18)30099-9 Weinberg, 1999, Ocular myasthenia gravis, Muscle Nerve, 22, 1222, 10.1002/(SICI)1097-4598(199909)22:9<1222::AID-MUS8>3.3.CO;2-I Rivero, 1995, Single-fiber electromyography of extraocular muscles, Muscle Nerve, 18, 943, 10.1002/mus.880180904 Oosterhis, 1989, The natural course of myasthenia gravis, J Neurol Neurosurg Psychiatry, 52, 1121, 10.1136/jnnp.52.10.1121 Evoli, 1996, A practical guide to the recognition and management of mysthenia gravis, Drugs, 52, 662, 10.2165/00003495-199652050-00004 Heitmiller, 1999, Myasthenia gravis, Semin Thorac Cardiovasc Surg, 11, 41, 10.1016/S1043-0679(99)70018-3 Roberts, 2001, Thymectomy in the treatment of ocular myasthenia gravis, J Thorac Cardiovasc Surg, 122, 562, 10.1067/mtc.2001.116191 Heitmiller, 1999, Myasthenia gravis, Semin Thorac Cardiovasc Surg, 11, 41, 10.1016/S1043-0679(99)70018-3 Tackenberg, 2001, Immunosuppressive treatment of ocular myasthenia gravis, BioDrugs, 15, 369, 10.2165/00063030-200115060-00003 Bonifati, 1997, Long-term cyclosporine treatment in a group of severe myasthenia gravis patients, J Neurol, 244, 542, 10.1007/s004150050141 Palace, 1998, A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis, Neurology, 50, 1778, 10.1212/WNL.50.6.1778 Jongen, 1998, High-dose intravenous immunoglobulin therapy for myasthenia gravis, J Neurol, 245, 26, 10.1007/s004150050170 Kupersmith, 1996, Beneficial effects of corticosteroids on ocular myasthenia gravis, Arch Ophthalmol, 53, 802 Mee, 2003, Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis, J Neuro-ophthalmol, 23, 251, 10.1097/00041327-200312000-00002 Cooper, 1987, 440 Cooper, 2000, Accommodative and Vergence Findings in Ocular Myasthenia, Neuro-Ophthalmol, 20, 5, 10.1097/00041327-200020010-00003 Cooper, 1978, Convergence Insufficiency, J Am Opt Assoc, 49, 673 Von Norden, 1996, Binocular Vision and Ocualr Motlity, CV Mosby, 408 Campbell, 1900, Myasthenia Gravis, Brain, 23, 277, 10.1093/brain/23.2.277